ASX - By Stock
|
PAA |
Re:
Pipeline-in-a-drug
|
|
Van1
|
61 |
11K |
18 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
61
|
11K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
Pipeline-in-a-drug
|
|
Van1
|
61 |
11K |
15 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
61
|
11K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
Van1
|
63 |
20K |
6 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
63
|
20K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Van1
|
560 |
135K |
4 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
560
|
135K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Van1
|
560 |
135K |
6 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
560
|
135K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Van1
|
560 |
135K |
4 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
560
|
135K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Van1
|
560 |
135K |
5 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
560
|
135K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Van1
|
560 |
135K |
12 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
560
|
135K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appointment of Company Secretary
|
|
Van1
|
4 |
1.8K |
18 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
4
|
1.8K
|
18
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Van1
|
560 |
135K |
29 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
560
|
135K
|
29
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Van1
|
560 |
135K |
6 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
560
|
135K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Van1
|
560 |
135K |
4 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
560
|
135K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
Van1
|
250 |
63K |
28 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
250
|
63K
|
28
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Van1
|
239 |
64K |
24 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
239
|
64K
|
24
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Van1
|
239 |
64K |
13 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
239
|
64K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Van1
|
239 |
64K |
40 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
239
|
64K
|
40
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Van1
|
317 |
82K |
1 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
317
|
82K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
Van1
|
104 |
20K |
5 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
104
|
20K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Van1
|
1.4K |
362K |
6 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
1.4K
|
362K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Van1
|
317 |
82K |
3 |
17/03/24 |
17/03/24 |
ASX - By Stock
|
317
|
82K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Van1
|
317 |
82K |
8 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
317
|
82K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Van1
|
317 |
82K |
12 |
03/03/24 |
03/03/24 |
ASX - By Stock
|
317
|
82K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Van1
|
1.4K |
362K |
6 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
1.4K
|
362K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Van1
|
1.4K |
362K |
5 |
24/02/24 |
24/02/24 |
ASX - By Stock
|
1.4K
|
362K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
Van1
|
323 |
77K |
11 |
24/02/24 |
24/02/24 |
ASX - By Stock
|
323
|
77K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: EGM Shareholder Presentation
|
|
Van1
|
45 |
13K |
7 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
45
|
13K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Van1
|
1.4K |
362K |
2 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
1.4K
|
362K
|
2
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Van1
|
1.4K |
362K |
3 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
1.4K
|
362K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Provides Clear Feedback for ODD Approval
|
|
Van1
|
323 |
77K |
16 |
29/01/24 |
29/01/24 |
ASX - By Stock
|
323
|
77K
|
16
|
|
ASX - By Stock
|
PAA |
Ann: PharmAust launches Interactive Investor Hub Dec 18,2023
|
|
Van1
|
1 |
766 |
5 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
1
|
766
|
5
|
|